Systane Complete Multi-symptom Relief

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

119 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-09

Study Completion Date

2022-03-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

NCT03492541

Dry Eye Disease

COMPLETED NA

Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye

NCT02446015

Dry Eye Syndrome

COMPLETED NA

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

NCT02470429

Dry Eye

COMPLETED NA

Systane Clinical Experience Study

NCT00818909

Dry Eye Syndrome

COMPLETED PHASE4

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

NCT04393441

Dry Eye Disease (DED)

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will be expected to attend a screening/baseline visit and one additional visit at Day 28 (± 2 days), with a telephone call visit conducted at Day 14 (± 2 days). Individual duration of subject participation will be approximately 28 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Systane Complete

First dose of Systane Complete in both eyes on Day 0, followed by Systane Complete self-administered 4 times daily for 28 days

Group Type EXPERIMENTAL

Systane Complete

Intervention Type OTHER

Propylene glycol 0.6% eye drops for replenishing deficiencies in both the lipid and aqueous layers of the tear film

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Systane Complete

Propylene glycol 0.6% eye drops for replenishing deficiencies in both the lipid and aqueous layers of the tear film

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Systane® Complete Lubricant Eye Drops

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to understand and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent form.
* Willing and able to attend all study visits as required per protocol.
* Have dry eye symptoms as specified in the protocol.
* Willing to discontinue use of all habitual artificial tear supplements for the entire study duration.

Exclusion Criteria

* Ocular conditions as specified in the protocol.
* Contact lens use within one week prior to screening visit.
* Use of medications as specified in the protocol.
* Pregnant or breast feeding.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No